Status:
COMPLETED
Long-Term Outcomes in the Treatment of Infantile and Acquired Esotropia With Botulinum Toxin
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Esotropia
Eligibility:
All Genders
1-5 years
Brief Summary
To investigate long-term treatment outcomes of patients receiving botulinum toxin A therapy for infantile and acquired esotropia.
Detailed Description
Participants: 164 patients with infantile esotropia and 89 patients with acquired esotropia. Methods: Patients were injected with botulinum toxin into two medial rectus muscles and followed from 1992...
Eligibility Criteria
Inclusion
- infantile esotropia and acquired esotropia
Exclusion
- exotropia, high AC/A ratio accommodative esotropia, patients with neurological deficit including cerebral palsy, Down syndrome and mental retardation, and ocular anomalies including retinopathy of prematurity. Patients lost to follow-up at 6 months or less after the last injection were also excluded.
Key Trial Info
Start Date :
September 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2007
Estimated Enrollment :
164 Patients enrolled
Trial Details
Trial ID
NCT00746304
Start Date
September 1 2007
End Date
December 1 2007
Last Update
September 3 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 100